SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) May 4, 1998
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On May 4, 1998 Biocontrol Technology, Inc.
(NASDAQ:BICO) announced today that the Company has signed an
agreement with Euro Surgical Ltd. for distribution of the Diasensor
1000 noninvasive glucose sensor in the United Kingdom (UK). Sales
of the device can begin there when Biocontrol receives approval to
apply the CE Mark to its device.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: May 4, 1998
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
For More Information, Call:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.279.9455 phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL SIGNS DISTRIBUTION CONTRACT FOR SALE OF DIASENSOR IN
UNITED KINGDOM
Pittsburgh, PA - May 4, 1998 - Biocontrol Technology, Inc.
(Nasdaq:BICO) announced today that the Company has signed an
agreement with Euro Surgical Ltd. for distribution of the
Diasensor 1000 noninvasive glucose sensor in the United Kingdom
(UK). Sales of the device can begin there when Biocontrol
receives approval to apply the CE Mark to its device.
Euro Surgical has its offices in Guidford, England, and is
involved in the marketing and sale of medical instruments and
devices to the medical profession in disciplines such as
obstetrics, gynecology, general surgery, urology, diabetes care,
and minimally invasive surgical instrumentation. Euro Surgical
exhibits at approximately thirty major medical meetings per year
in the UK and advertises regularly in major medical journals.
Recent annual sales were approximately $4.5 million.
Euro Surgical has been appointed exclusive distributor for
the Diasensor in the UK, comprising the territories of England,
Scotland, Wales, Northern Ireland, and The Republic of Ireland.
The agreement is for a 12-month period and is renewable for
successive terms. In addition to sales, Euro Surgical will be
responsible for service.
Euro Surgical's Chairman and Managing Director, George
Cranstone, met with personnel at Biocontrol's Indiana, PA
facilities, where he reviewed patient data collected from
clinical testing and toured the manufacturing, research, and
clinical facilities. He also visited in a home of a patient
involved in Biocontrol's testing program to discuss the practical
application of the Diasensor and see it in use. Mr. Cranstone
has been the director of Euro Surgical for 10 years. For 14
years prior to forming Euro Surgical, he was the sales director
of a major medical marketing company in England. His background
includes cardiovascular products, anesthetics, orthopedics,
diabetes products, as well as products used in other disciplines.
He currently imports products from several US companies into the
UK.
Biocontrol Technology, Inc. (www.bico.com) has its corporate
offices in Pittsburgh, PA and is involved in the development and
manufacture of biomedical devices and environmental products.
